Guides safe medication administration with rights verification, timing, and documentation requirements. Use when administering medications, documenting med administration, or managing medication timing.
Medication errors are the most common type of healthcare error, with the Institute for Safe Medication Practices (ISMP) identifying administration as the highest-risk phase of the medication use process. The Joint Commission NPSG.03.04.01 requires labeling of all medications and solutions. NPSG.03.05.01 mandates anticoagulant safety protocols. NPSG.03.06.01 requires medication reconciliation at transitions. CMS Conditions of Participation (§482.23) require that drugs and biologicals are administered per physician orders and accepted standards of practice. The ANA Scope and Standards designate medication administration as a core nursing competency requiring clinical judgment — not just task completion. This skill ensures safe, accurate, well-documented medication administration aligned with current evidence-based practice.
Checkpoint A — Intake Verification
Required Before Medication Administration
Valid medication order with all required elements: patient name, medication name, dose, route, frequency, indication (where required by facility policy)
Related Skills
Allergy status verified and documented — including type of reaction for each allergy
Current medication reconciliation complete
Patient weight in kilograms for weight-based dosing
Relevant laboratory values checked (e.g., INR for warfarin, potassium for KCl, renal function for renally-cleared drugs, vancomycin trough)
Patient assessment appropriate to the medication (e.g., heart rate before beta-blockers or digoxin, BP before antihypertensives, blood glucose before insulin, respiratory rate before opioids)
High-alert medication independent double-check completed if applicable
High-Alert Medication Identification
Per ISMP High-Alert Medications List, the following require enhanced safeguards:
Step 1 — Verify the Ten Rights of Medication Administration
Perform rights verification at three checkpoints: when retrieving from storage, when preparing, and at the bedside before administration.
Right Patient — verify using two identifiers (name + DOB or name + MRN); never use room number as an identifier
Right Medication — compare label to MAR; for sound-alike/look-alike medications (ISMP list), use tall-man lettering awareness
Right Dose — confirm dose is appropriate for age, weight, renal/hepatic function; perform dosage calculation if needed
Right Route — verify the ordered route; confirm patient can receive via that route (e.g., can swallow PO, has IV access for IV)
Right Time — administer within 30 minutes before or after scheduled time (per CMS interpretive guidance); time-critical medications have narrower windows
Right Documentation — document immediately after administration, never before
Right Reason — understand the clinical indication; question orders that lack clinical justification
Right Assessment — perform pre-administration assessment specific to the medication
Right Education — inform the patient about the medication name, purpose, expected effects, and what to report
Right Evaluation — plan and perform post-administration assessment for therapeutic and adverse effects
Scan each medication to verify against the electronic MAR
Address any BCMA override alerts — document clinical rationale for any alert overridden
Never pre-scan or batch-scan medications before reaching the patient's bedside
Report BCMA system downtime per institutional downtime medication administration procedure
Document BCMA scanning compliance for unit-level quality metrics
Step 3 — Execute Route-Specific Administration
Oral Medications
Verify swallowing ability; assess for dysphagia risk
Elevate HOB to at least 30 degrees before administering
Do not crush extended-release, enteric-coated, or sublingual formulations — consult pharmacy for alternatives
Administer with appropriate fluid unless fluid-restricted
Intravenous Medications
Verify IV site patency and assess for infiltration/phlebitis (INS phlebitis scale)
Confirm compatibility with running infusions — use separate lumens or flush between incompatible drugs
Program smart pump with drug library entry; verify rate, concentration, and total volume
For IV push medications: confirm push rate per pharmacy reference (e.g., IV push morphine over 4–5 minutes)
Subcutaneous / Intramuscular Injections
Select appropriate site and needle length for patient body habitus
Rotate injection sites for repeated doses (insulin, heparin)
For insulin: verify type, dose, and units with independent double-check; use insulin-specific syringes only
For IM: aspirate per current evidence and institutional policy (note: aspiration no longer recommended for most IM sites except dorsogluteal per CDC immunization guidelines)
Topical, Rectal, Ophthalmic, Otic, Inhaled
Follow route-specific administration technique
Document exact site of application for topical medications
For inhaled medications: assess technique and provide spacer if appropriate
Step 4 — Manage High-Alert Medications
Independent double-check by a second RN for: insulin, heparin infusions, PCA settings, chemotherapy, blood products, pediatric weight-based doses, and other facility-designated high-alert medications
Double-check must verify: right patient, right medication, right dose, right route, right rate (for infusions), pump settings, and dosage calculation
Document the double-check with both nurses' signatures
Smart pump hard stops must never be overridden for high-alert medications without pharmacist consultation
Titration protocols: follow evidence-based titration parameters (e.g., insulin drip per institutional glycemic management protocol; heparin per weight-based nomogram)
Step 5 — Monitor Post-Administration
Assess for therapeutic effect at the expected onset time:
IV morphine: 5–10 minutes
PO acetaminophen: 30–60 minutes
Insulin lispro: 15–30 minutes
IV furosemide: 5 minutes (diuresis within 30 min)
Monitor for adverse effects and allergic reactions
Document patient response in the clinical notes
Report adverse drug reactions to the provider and pharmacy
Submit MedWatch (FDA) reports for serious adverse events per institutional policy
Reassess pain within 1 hour PO / 30 minutes IV per institutional pain reassessment protocol
Step 6 — Document Medication Administration
Record in the electronic MAR: medication name, dose, route, site (for injections), time administered, administering nurse
Document post-administration evaluation including patient response
Record patient refusal with reason stated, education provided about consequences, and provider notification
Document held medications with clinical rationale (e.g., "Metoprolol 25mg PO held — HR 52, physician notified at 0830, order received to hold if HR < 60")
Record PRN medication indication at time of administration and effectiveness at reassessment
Checkpoint B — Shift Medication Review
End-of-Shift Verification
All scheduled medications administered or accounted for (given, held, refused, patient off unit)
All PRN medications have documented indication and effectiveness reassessment
All held medications have clinical rationale and provider notification documented
No overdue medications pending
Controlled substance count reconciled per institutional policy
High-alert medication double-checks all documented with two RN signatures
ANA Position Statement: Safe medication administration requires clinical judgment, assessment, and monitoring — not mere task performance
Controlled substances: DEA Schedule II–V medications require additional documentation, reconciliation, and chain-of-custody per federal and state law
Scope of practice: RN independently administers medications per valid order; LPN/LVN administers per state Nurse Practice Act (IV push often restricted to RN); student nurses administer under direct RN supervision
Error reporting: Report all medication errors and near-misses per institutional policy; foster a just culture approach that focuses on system improvement rather than individual blame
Look-alike/sound-alike: Use tall-man lettering (e.g., DOBUTamine vs. DOPamine, hydrALAZINE vs. hydrOXYzine) and physical separation in storage